A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.
about
Recent advances in treating Parkinson's disease.Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias.Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs.Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.The role of alpha7 nicotinic acetylcholine receptors in inflammatory bowel disease: involvement of different cellular pathways.
P2860
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A Placebo-Controlled Trial of ...... e Levodopa-Induced Dyskinesia.
@en
A Placebo-Controlled Trial of ...... e Levodopa-Induced Dyskinesia.
@nl
type
label
A Placebo-Controlled Trial of ...... e Levodopa-Induced Dyskinesia.
@en
A Placebo-Controlled Trial of ...... e Levodopa-Induced Dyskinesia.
@nl
prefLabel
A Placebo-Controlled Trial of ...... e Levodopa-Induced Dyskinesia.
@en
A Placebo-Controlled Trial of ...... e Levodopa-Induced Dyskinesia.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
A Placebo-Controlled Trial of ...... e Levodopa-Induced Dyskinesia.
@en
P2093
Alberto J Espay
Alexander Storch
Andres Ceballos-Baumann
Andrew Feigin
Annamaria Jakab
Baltazar Gomez-Mancilla
Christian Geny
Dominik Feuerbach
Donald Johns
Emmanuel Broussolle
P2860
P356
10.1002/MDS.26569
P407
P50
P577
2016-03-15T00:00:00Z